Clinical Trial Update: Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy [Phase 2]

View source ↗

Summary

This document reports the completed status of a Phase 2 neoadjuvant trial in early breast cancer comparing letrozole alone versus letrozole with zoledronic acid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED